Action SEC SENVEST CAPITAL INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Senvest Capital Inc.

Actions

SEC

CA81731L1094

Temps Différé Toronto S.E.
Autres places de cotation
 17:20:21 29/04/2024 		Varia. 5j. Varia. 1 janv.
290 CAD +1,75% Graphique intraday de Senvest Capital Inc. +1,75% -6,45%
29/03 Senvest Capital Inc. publie ses résultats pour l'exercice clos le 31 décembre 2023 CI
2023 Senvest Capital Inc. publie ses résultats pour le troisième trimestre et les neuf mois se terminant le 30 septembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
North American Morning Briefing : Focus Turns to -2-
Biolinq Incorporated announced that it has received $58 million in funding from a group of investors
Senvest Capital Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Senvest Capital Brief: Reporting net income attributable to common shareholders of $83.6 million or $33.78 per share for year ended December 31, 2023
Senvest Capital Reports Results for the Year Ended December 31, 2023
Biolinq Incorporated announced that it expects to receive funding
Tranche Update on Senvest Capital Inc.'s Equity Buyback Plan announced on August 11, 2022.
Tranche Update on Senvest Capital Inc.'s Equity Buyback Plan announced on August 11, 2023.
Senvest Capital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Senvest Capital Brief: Reported net loss attributable to common shareholders of ($67.0) million or ($27.07) per share for Q3
Senvest Capital Inc. Reports Results for the Third Quarter Ended September 30, 2023
Senvest Capital Inc. Reports Results for the Third Quarter Ended September 30, 2023
Senvest Capital Inc.'s Equity Buyback announced on August 11, 2022, has expired with 13,000 shares, representing 0.52% for CAD 3.96 million.
Senvest Capital Obtains TSX Consent For Normal Course Issuer Bid
Senvest Capital Inc. announces an Equity Buyback for 100,000 shares, representing 4.04% of its issued share capital.
Senvest Capital Brief: Announcing Acceptance by TSX of Normal Course Issuer Bid
Senvest Capital Inc. Announces Acceptance by TSX of Normal Course Issuer Bid
Senvest Capital Inc. Announces Acceptance by TSX of Normal Course Issuer Bid
Senvest Capital Inc. authorizes a Buyback Plan.
Senvest Capital Brief: Reporting Q2 Diluted earnings (loss) per share attributable to common shareholders of $8.58
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action SEC
  4. Actualités Senvest Capital Inc.
  5. Autres langues